ZS Pharma (Forth Worth, TX), a clinical-stage pharmaceutical company focused on the development of therapies to treat kidney and liver disease, closed a $46M Series C. Participants include Alta Partners, RiverVest Venture Partners, 3×5 Special Opportunity Partners, Salem Partners and Devon Park Bioventures.

Collective IP | The Most Comprehensive and Accurate View of Global Innovation and Organization of the International Technology Transfer Office Ecosystem

Request Collective IP Account Access HERE